Skip to content

The Effectiveness of Self-thoracic Spine Mobilization on Improving Sleep Quality in Patients Who Have Shoulder Pain

CompletedNot applicableNCT03088085
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

This project aims to study the impacts of self-thoracic spine and rib mobilization on sleep quality in patients who present to UTSW physicians with shoulder pain. The investigators plan to randomize participants into treatment and control groups, but the investigators will provide education on sleep hygiene for each group. The treatment group will also receive instruction to mobilize their thoracic spine and ribs each night before going to sleep.

Study details

Official title
The Effectiveness of Self-thoracic Spine Mobilization on Improving Sleep Quality in Patients Who Have Shoulder Pain
Interventions
  • Procedure: Self-mobilization
  • Procedure: Sleep Education
Sponsor
University of Texas Southwestern Medical Center
Start date
2017-02-20
Primary completion
2019-10-01
Sex
All
Age range
from 18 Years to 89 Years
Results posted
No results posted in this snapshot
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Shoulder pain with associated sleeping disturbance * Between the ages of 18-89 * Present to the clinics in the Departments of Internal Medicine, Family Medicine, and Orthopedic Surgery at UTSW Exclusion Criteria: * non-English speakers * chronic pain or rheumatic disorders * unstable psychopathology, cognitive impairment (including dementia) * current or recent history (within 6 months) of substance abuse disorders * recent history of surgery or fracture to the cervical spine, thoracic spine, ribs, or shoulders (within 6 months) * metabolic bone disease (including osteoporosis) * fusion or ankyloses * osteomyelitis, pregnancy, vertebral basilar insufficiency, neoplastic disease, malignancy in the area of treatment * actively treated for sleep disorders (including insomnia) * uncontrolled congestive heart failure, COPD, hypertension, or other serious medical illness

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03088085